Medical Hypotheses
Volume 56, Issue 1 , Pages 52-57 , January 2001

Cell darwinism, apoptosis, free radicals and haematological malignancies

Received 9 December 1999 ,Accepted 28 February 2000.

References 

    REFERENCES
  1. Dennet DC. Universal acid. Darwin’s Dangerous Idea. 1995;61–84
  2. Ramel C. Evolutionary aspects of human cancer. Pharmacogenetics. 1992;2:344–349
  3. La Torre F, Silpigni A, Tomasello R. Cellular adaptation and cancerogenesis. Minerva Med. 1998;89:229–239
  4. Bedi A, Sharkis SJ. Mechanisms of cell commitment in myeloid cell differentiation. Curr Opin Hematol. 1995;2:12–21
  5. McCarthy NJ, Smith CA, Williams GT. Apoptosis in the development of the immune system: growth factors, clonal selection and bcl-2. Cancer Metastasis Rev. 1992;11:157–178
  6. Nossal GJ. B lymphocyte physiology: the beginning and the end. Ciba Found Symp. 1997;204:220–230
  7. Coffey DS. Self-organization, complexity and chaos: the new biology for medicine. Nature Medicine. 1998;4:882–885
  8. Binder C, Hiddemann W. Programmed cell death – many questions still to be answered. Ann Hematol. 1994;69:45–55
  9. Skuse GR, Ludlow JW. Tumour suppressor genes in disease and therapy. Lancet. 1995;345:902–906
  10. Lane DP. p53, guardian of the genome. Nature. 1992;358:15–16
  11. Peter ME, Krammer PH. Mechanisms of CD95 (APO-1/Fas)- mediated apoptosis. Curr Opin Immunol. 1998;10:545–551
  12. Agami R, Blandino G, Oren M, Shaul Y. Interaction of c-Abl and p73á and their collaboration to induce apoptosis. Nature. 1999;399:809–813
  13. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science. 1998;281:1322–1326
  14. Tomei LD, Umansky SR. Aging and apoptosis control. Neurol Clin. 1998;16:735–745
  15. Warner HR, Hodes RJ, Pocinky K. What does cell death have to do with aging?. J Am Geriatr Soc. 1997;45:1140–1146
  16. Greiner TC, Medeiros LJ, Jaffe ES. Non-Hodgkin’s lymphoma. Cancer. 1995;75:370–380
  17. Reed JC. Regulators of apoptosis in B-cell neoplasms. Ann Oncol. 1999;Suppl 3:21
  18. Imamura J, Miyoshi I, Koeffler P. p53 in hematologic malignancies. Blood. 1994;8:2412–2421
  19. McGahon A, Bisonette R, Schmitt M. BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic death. Blood. 1994;83:1179–1186
  20. Biernaux C, Sels A, Stryckmans P. Very low level of major BCR-ABL expression in blood of some healthy individuals. Bone Marrow Transplantation. 1996;17:S45–47
  21. Bose S, Deininger M, Gora-Tybor J. The presence of typical and atypical BCR-ABL fusion genes in leucocytes of normal individuals: biologic significance and implications for the assessment of minimal residual disease. Blood. 1998;92:3362–3367
  22. Butturini A, Gale RP. Relationship between clonality and transformation in acute leukemia. Leukemia Research. 1991;1:1–7
  23. Champion KM, Gilbert JG, Asimakoupulos FA. Clonal hematopoiesis in normal elderly women: implications for the myeloproliferative disorders and myelodysplastic syndromes. Br J Haematol. 1997;97:920–926
  24. Blade J, Guillermo AL, Rozman C. Malignant transformation and life expectancy in monoclonal gammopathy of undetermined significance. Br J Haematol. 1992;81:391–394
  25. Parker JE, Mufti GJ. Ineffective haemopoiesis and apoptosis in myelodysplastic syndromes. Br J Haematol. 1998;101:220–230
  26. van Kamp H, Landegent JE, Jansen RP. Clonal hematopoiesis in patients with acquired aplastic anemia. Blood. 1991;78:3209–3214
  27. Rotoli B, Luzzato L. Paroxysmal nocturnal hemoglobinuria. Sem Hematol. 1989;36:201–205
  28. Takeda J, Myata T, Kawagoe K. Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell. 1993;73:703–711
  29. Sverdlow SH. Post-transplant lymphoproliferative disorders: a morphologic, phenotypic and genotypic spectrum of disease. Histopathology. 1992;20:373–385
  30. Aboulafia D. Epidemiology and pathogenesis of AIDS-related lymphomas. Oncology. 1998;12:1068–1081
  31. Epstein CJ, Motulsky AG. Werner syndrome: entering the helicase era. Bioessays. 1996;18:1025–1027
  32. Garcia-Higuera I, Kuang Y, D’Andrea AD. The molecular and cellular biology of Fanconi anemia. Curr Opin Hematol. 1999;6:83–88
  33. Frassoni F, Podesta M, Piaggio G. Normal primitive haematopoietic progenitors are more frequent than their leukaemic counterpart in newly diagnosed patients with chronic myeloid leukaemia but rapidly decline with time. Br J Haematol. 1998;104:538–545
  34. Mathieu J, Chancerelle Y, Herodin F. Oxidative stress and apoptosis. Ann Pharm Fr. 1996;54:193–201
  35. Lenaz G. Role of mitochondria in oxidative stress and ageing. Biochim Biophys Acta. 1998;1366:53–67
  36. Richter C. Reactive oxygen and nitrogen species regulate mitochondrial Ca2+ homeostasis and respiration. Biosci Rep. 1997;17:53–66
  37. Hampton MB, Fadeel B, Orrenius S. Redox regulation of caspases during apoptosis. Ann NY Acad Sci. 1998;854:328–335
  38. Papa S, Skulachev VP. Reactive oxygen species, mitochondria and aging. Mol Cell Biochem. 1997;174:305–319
  39. Johns DR. Mitochondrial DNA and disease. N Eng J Med. 1993;333:638–644
  40. Korsmeyer SJ, Yin XM, Oltvai ZN. Reactive oxygen species and the regulation of cell death by the Bcl-2 family. Biochim Biophys Acta. 1995;1271:63–66
  41. Amarante-Mendes G, Kim CN, Liu L. Bcr-Abl exerts its antiapoptotic effect against diverse apoptotic stimuli through blockage of mitochondrial release of cytochrome c and activation of caspase-3. Blood. 1998;91:1700–1705
  42. Zheng A, Mantymaa P, Saily M. An association between mitochondrial function and all-trans retinoic acid-induced apoptosis in acute myeloblastic leukemia cells. Br J Haematol. 1999;105:215–224
  43. Kobryn CE, Fiskum G. Differential sensitivity of AS-30D rat hepatoma cells and normal hepatocytes to anoxic cell damage. Am J Physiol. 1992;262:1384–1387
  44. Hamilton E, Fennell M, Stafford DM. Modification of tumor glucose metabolism for therapeutic benefit. Acta Oncol. 1995;34:429–433
  45. Griffini P, Freitas I, Vigorelli E, Van Noorden CJ. Changes in the zonation of lactate dehydrogenase activity in lobules of rat liver after experimentally induced colon carcinoma metastases. Anticancer Res. 1994;14:2537–2540
  46. Jonasova A, Neuwirtova R, Cermak J. Cyclosporin A therapy in hypoplastic MDS patients and certain refractory anemias without hypoplastic bone marrow. Br J Haematol. 1997;100:304–309
  47. Bassan R, Rambaldi A, Amaru R. Unexpected remission of acute myeloid leukemia after GM-CSF. Br J Haematol. 1994;87:835–838
  48. Isaacson PG. Gastrointestinal lymphomas of T and B-cell type. Mod Pathol. 1999;12:151–158
  49. Reinacher-Schick A, Petrasch S, Burger A. Helicobacter pylori induces apoptosis in mucosal lymphocytes in patients with gastritis. Z Gastroenterol. 1998;36:1021–1026
  50. Cummings JH, Bingham SA. Diet and the prevention of cancer. BMJ. 1998;317:1636–1640
  51. Gerber M, Corpet D. Energy balance and cancers. Eur J Canc Prevent. 1999;8:77–89

PII: S0306-9877(00)91108-3

doi: 10.1054/mehy.2000.1108

Medical Hypotheses
Volume 56, Issue 1 , Pages 52-57 , January 2001

Article Tools